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Bioguided fractionation of the aqueous extract of Thonningia sanguinea flowers, used traditionally in 
the treatment of microbial diseases, led to the isolation of two phenolic compounds. The structure of 
these compounds was elucidated by 1H, 13C 1D NMR and mass spectrometry experiments. The 
antibacterial activity against Salmonella strains and antioxidant activity of the crude extract, fractions 
and isolated compounds was evaluated using the DPPH method. The isolated compounds identified as 
brevifolin carboxylic acid and gallic acid demonstrates moderate antibacterial activity against 
Salmonella enteritidis, Salmonella typhimurium, and Salmonella abony. The results indicated that the 
two isolated compounds, gallic acid (IC50 = 13.5 µM) and brevifolin carboxylic acid (IC50 = 18.0 µM) were 
mainly responsible for the good scavenging activity of the aqueous extract. 
 






Over the years, natural products have contributed enor-
mously to the development of important therapeutic drugs 
used currently in modern medicine (Hostettmann et al., 
1995; Cragg et al., 1997; Shu, 1998). In Africa and else-
where, the use of indigenous plants plays an important 
role in the treatment of microbial diseases. For instance, 
the flowers of Thonningia sanguinea are largely used in 
Ivory Coast in the treatment of microbial diseases mainly 
the salmonellae diseases (Guédé-guina, 2003). In Africa, 
multidrug-resistant non-typhoidal salmonellae (NTS) are 
one of the leading causes of morbidity and high mortality 
in children under 5 years old (Kariuki et al., 2006). T. san- 
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(Gyamfi et al., 1999; Atawodi, 2006). 
In recent years, the studies on “oxidative stress” and its 
adverse effects on human health have become a subject 
of considerable interest. It is well documented fact that 
exposure of organism to exogenous and endogenous 
factors generates a wide range of reactive oxygen spe-
cies resulting in homeostatic imbalance (Halliwell et al., 
1992). Many efforts have been made to discover new 
antimicrobial and antioxidant compounds from various 
kinds of sources such as micro-organisms, animals, and 
plants. Systematic screening of folk remedies is another 
strategy in the discovery of novel effective compounds 
(Walter and Memory, 1995). 
Previous study on T. sanguinea reported the isolation 
of two antioxidant ellagitannins from the stem bark (Ohta-
ni et al., 2000). As part of our continuing search for bio-
logically active compounds from Ivorian plants, we have 
examined the aqueous extract of flowers of T. sanguinea.
 




 Table 1. 1H (300 MHz) and 13C (200 MHz) NMR data for compounds 1 and 2 in CD3OD 
. 
 Compound 1  Compound 2 
n° 13C () 1H () N° 13C () 1H () 
1 175.4  1 170.3  
2 41.5 4,5 (dd) (1.2; 7.5) 2 121.9  
3 37.7 2,6 (dd) (1.2; 18.8) 
3,0 (dd) (7.5; 18.8) 
3 110.3 7.05 (d) (2.9) 
4 194.6  4 146,3  
4a 149.7  5 139,5  
4b 115.4  6 146,3  
5 -------  7 110,3 7.05 (d) (2.9) 
6 161.5     
6a 114.0     
7 108.3 7.3 (s)    
8 143.9     
9 140.9     
10 146.3     




We report here the anti-salmonella and antioxidant 
activity of the aqueous extract, fractions and isolated 
compounds from the flowers of T. sanguinea. 
 
 
MATERIALS AND METHODS 
 
The present study was performed according to international, 





T. sanguinea flowers were collected in Adzopé, Ivory Coast and 
identify by Pr Aké-Assi of the Department of Botany, University of 
Cocody- Abidjan. A voucher specimen (Voucher n° 14162) is 
deposited in the herbarium of “Centre National de Floristique” of 
Abidjan. 
The freshly collected flowers of the plant were air dried at room 
temperature for 7 days and powdered. Briefly 20 g of powder was 
soaked in 500 ml distilled water for 24 h with constant stirring. The 
suspension was further filtered through Whatmann (N°1) filter paper. 
The filtrate was concentrated in vacuo using a rotary evaporator to 
obtain the aqueous extract. The aqueous extract (20 g) was 
extracted successively with cyclohexane, ethyl acetate and butanol 
to yield three main fractions labelled F1 (0.18 g), F2 (0.8 g), F3 (1.5 
g) and a residue (14.8 g). The disc diffusion assay was used to 
perform bioguided fractionation (Table 1). The active fraction F3 
(1.5 g) was fractionated by column chromatography on Sephadex 
LH20 (25 cm x 2.2 cm diameter) using methanol as eluent. 
Twenty sub-fractions of 20 mL were collected and pooled on the 
basis of their TLC profiles. Two main sub-fractions labelled F1-8 
(Fb1) and F9-20 (Fb2) were obtained. The active sub-fraction Fb2 
(210 mg) was purified by preparative HPLC (H2O-ACN; 95 - 5% to 
0 - 100% in 35 min, flow rate = 5.0 mL/min) to afford compound (1) 
(Rt = 10.5 min, 17 mg).  
The ethyl acetate fraction F2 was fractionated on Sephadex 
LH20  using  MeOH  as eluent. Twenty fractions of 20 mL were coll-
ected and pooled on the basis of their TLC profiles. Three main 
sub-fractions Fa1 to Fa3 were obtained. The active sub-fraction 
Fa1 was purified by preparative HPLC (H2O-ACN; 95 - 5% to 0 - 
100% in 35 min, flow rate = 5.0 mL/min) to afford compound (2) (Rt 
= 7.9 min, 20 mg).  
 
 
Disc diffusion assay 
 
Base plates were prepared by pouring 10 mL Mueller-Hinton (MH) 
agar into sterile Petri dishes (9 cm) and allowed to set. Molten Filter 
paper discs (Watmann no 1; 6 mm) were impregnated with the 
aqueous extract and the different fractions (5 mg/disc). The discs 
were air-dried and placed on the top layer of the agar plates. Each 
extract was tested in triplicate with a chloramphenicol (30 µg/disc) 
as reference or positive control. Water saturated disc (air-dried) 
were used as negative controls. The sensitivity was recorded by 
measuring the clear zone of growth inhibition on agar surface 
around the discs (Bauer et al., 1966). 
 
 
Determination of Minimum Inhibitory Concentration (MIC) 
 
The Minimum Inhibitory Concentration (MIC) was determined 
according to Wilkinson and Gentry (1981). Two-fold dilutions (six) of 
test substances (extract, fractions, isolated compounds) were 
carried out starting from the concentration of 5 mg/mL. The tubes 
were inoculated with a microorganism suspension at a density of 
105 cells/mL. Each tube was incubated at 37°C for 24 h. The lowest 
concentration of the tube which did not show any visible growth 
after macroscopic evaluation was considered as the MIC. 
Gentamycin was used as positive control. 
 
 
DPPH free radical scavenging activity 
 
The free radical scavenging activity of the extracts, fractions and 
pure compounds were measured from the bleaching of purple colo-
ured methanol solution of DPPH. This spectrophotometric assay 
uses stable radical diphenylpicrylhydrazyl (DPPH) as a reagent 
(Cuendet et al., 1997). Five hundred (500) µL of various concentra- 
trations using serial 2-fold dilutions of the extract, the fractions and 
pure compounds in methanol was added to 1 mL of a solution of 
DPPH (0.02 mg/mL). After a 20 min incubation period at room 
temperature, the absorbance was read against a blank at 517 nm. 
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The tests were carried out in triplicate. The inhibitory percentage of 
DPPH was calculated according to the following equation: Scaven-
ging effect (%) = [(A0-A1)/A0] x 100, where A0 was the absorbance 
of the control and A1 was the absorbance in the presence of 
samples and standard (quercetol). The amount of sample in µg/ml 
at which the absorbance at 517 nm decreases to half its initial value 





The approach for structural elucidation was based on spectroscopic 
methods, including mass spectra (MS) using HR-ESI-TOF mass 
spectrometry (MICRO TOF, Bruker Daltonique), 1H and 13C nuclear 
magnetic resonance (NMR) experiments recorded on Bruker 
Avance 300 (300 MHz for 1H and 200 MHz for 13C). For NMR analy-
sis, compounds 1, 2 were dissolved in 0.50 mL of CD3OD. The 
structure of compounds 1 and 2 were determined by comparison of 





Structure of isolated compounds 
 
Compound (1) was isolated as yellow powder, mp 200 - 
201°C, and gave a positive reaction with ferric chloride, 
indicating its phenolic nature. Its elemental composition 
C13H8O8 with 10 degrees of insaturation in the molecule 
was determined according to the high resolution 
electrospray ionisation mass spectrometry (ESI-TOF-MS), 
1H and 13C RMN spectroscopy. These data permitted us 
to identify (1) with brevifolin carboxylic acid (Figure 1), 
previously isolated from Erodium cicutarium (Fecka et al., 
2001). 
Colouring reagents, UV-light fluorescence (254 and 
365 nm), comparison of 1H and 13C NMR data and 
comparison with a known standard (Sigma) permitted us 
to identify (2) with gallic acid (Figure 1) (Ohtani et al., 
2000). The NMR data of the two compounds are indica-
ted in Table 1. Assignments were confirmed by COSY, 
HMBC and DEPT experiments. 
Antibacterial and antioxidant activities 
 
The aqueous extract of T. sanguinea dried flowers was 
tested for its antibacterial activity against Salmonella ent-
eritidis, Salmonella typhimurium and Salmonella abony, 
and its antioxidant activity using the DPPH radical sca-
venging activity. The results showed bacterial inhibition 
(MIC = 5 mg/mL; Table 2) and radical scavenging activity 
(CI50 = 19.0 µg/mL; Table 3). The aqueous extract was 
successively fractionated with cyclohexane, ethyl acetate 
and butanol. Brevifolin carboxylic acid, isolated by 
bioguided fractionation from the butanolic fraction (MIC = 
2.5 mg/mL; Table 2), exhibited weak antibacterial activity 
against S. enteritidis, S. typhimurium and S. abony (MIC 
> 1600 µg/mL; Table 1) while gallic acid, isolated from 
the ethyl acetate fraction, showed mild activity (MIC = 
1600 mg/mL; Table 2). 
In addition to antimicrobial evaluation, the isolated 
compounds were evaluated for their antioxidant activity 
using the free radical scavenging activity of the DPPH 
radical. The good activity observed with gallic acid (IC50 
2.3 µg/mL = 13.5 µM) and brevifolin carboxylic acid (IC50 
5.2 µg/mL = 18.0 µM) indicated that these compounds 
are mainly responsible for the free radical scavenging 
activity of the aqueous extract of dry flowers of this spe-





Salmonellosis and Typhoid fever are always public health 
concern problem in several countries around the world. 
These are mostly low-or middle-income countries with 
inadequate sanitation and hygiene, particularly regarding 
food, water and disposal of human excreta (Jesudason 
and Sivakumar, 2006). 
In order to provide scientific supports to the use of the 
flowers of T. sanguinea, a Balanophoraceae used in Ivory 
Coast by Traditional practitioner to treat diarrhoeal disea- 
 




Table 2. Minimum Inhibitory Concentration (MIC) values of active extracts, fractions, isolated compounds and 
gentamycin. 
 







Gallic acid Gentamycin 
S. enteritidis 5 2.5 >1.6 1.6 8.10-3 
S. abony 5 2.5 >1.6 1.6 8.10-3 
S. typhimurium 5 2.5 >1.6 1.6 8.10-3 
 
 
Table 3. IC50 values of the aqueous extract and isolated compounds. 
 
DPPH radical scavenging activity Sample 
IC50 (µg/mL) IC50 (µM) 
Aqueous extract 19.0 - 
Ethyl acetate fraction 19.0 - 
Fa1 15.5 - 
Fa2 23.0 - 
Fa3 30.2 - 
Butanolic fraction 11.0 - 
Residue 35.0 - 
Brevifolin carboxylic acid 5.2 18.0 
Gallic acid 2.3 13.5 




se and salmonellosis, we have tested its aqueous extract 
against S. enteritidis, S. abony, and S. typhimurium. We 
have also isolated two compounds identified as gallic 
acid and brevifolin carboxylic acid. 
Surprisingly, the bioguided fractionation led to the 
isolation of compounds with weak antibacterial activities. 
Gallic acid is known to possess moderate antibacterial 
activity against Salmonella cholaerasius (Kubo et al., 
2002) and there is no scientific report concerning brevifo-
lin carboxylic acid antibacterial activity. The presence of 
gallic acid in the aqueous extract of T. sanguinea flowers 
may partly explain the traditional use of this plant against 
Salmonella previously described by Vangah-Manda et al. 
(1994). The presence of tannins in this species, some of 
which are known to possess potent antibacterial activity 
(Scalbert, 1991), suggest that the antimicrobial activity of 
the aqueous extract of dry flowers of T. sanguinea is pro-
bably due to the synergistic activity of several polyphe-
nolic compounds. 
Plant compounds are routinely classified as “antimicro-
bial” on the basis of susceptibility tests that produce MICs 
in the range of 100 to 1000 µg/mL, orders of magnitude 
weaker than those of typical antibiotics produced by 
bacteria and fungi (MICs, 0.01 to 10 µg/mL). A secondary 
metabolite or compound which shows little activity in an 
in vitro susceptibility test is not necessarily an antimicro-
bial. Such a substance might have a regulatory function 
(Tegos et al., 2002).  
The importance of reactive oxygen species (ROS) and 
free radicals has attracted increasing attention over the 
past decade. ROS which include free radicals such as 
superoxide anion radicals, hydroxyl radicals and non-free 
radical species such as oxygen peroxide and singlet oxy-
gen, are various forms of activated oxygen. These mole-
cules exacerbate factors in cellular injury and aging pro-
cess (Halliwell and Gutterigde, 1989). The harmful action 
of free radicals can be blocked by antioxidant substances, 
which scavenge the free radicals and detoxify the orga-
nisms. 
In this context, we have also investigated the antioxi-
dant properties of the aqueous extract of T. sanguinea 
and the isolated compounds. The results showed high 
antioxydant properties of the extract and the two isolated 
compounds.  
Gallic acid is well known as a potent antioxidant com-
pound (Lu et al., 2006). The antioxidant activity of brevi-
folin carboxylic acid is probably related with the presence 
of various acidic phenolic protons. These results may be 
related with those of Gyamfi et al. (1999) who showed 
that the root extract of T. sanguinea possesses antioxy-
dant activity. Brevifolin carboxylic acid is isolated for the 
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